Abstract
Heart failure with preserved ejection fraction (HFpEF) represents a major unmet therapeutic need. This study investigated whether feeding coconut oil (CC diet) for 26 weeks in female C57BL/6N mice induces HFpEF and evaluated the effect of reconstituted high-density lipoprotein (HDL) Milano (MDCO-216) administration on established HFpEF. Eight intraperitoneal injections of MDCO-216 (100 mg/kg protein concentration) or of an equivalent volume of control buffer were executed with a 48-h interval starting at 26 weeks after the initiation of the diet. Feeding the CC diet for 26 weeks induced pathological left ventricular hypertrophy characterized by a 17.1% (p < 0.0001) lower myocardial capillary density and markedly (p < 0.0001) increased interstitial fibrosis compared to standard chow (SC) diet mice. Parameters of systolic and diastolic function were significantly impaired in CC diet mice resulting in a reduced stroke volume, decreased cardiac output, and impaired ventriculo-arterial coupling. However, ejection fraction was preserved. Administration of MDCO-216 in CC diet mice reduced cardiac hypertrophy, increased capillary density (p < 0.01), and reduced interstitial fibrosis (p < 0.01). MDCO-216 treatment completely normalized cardiac function, lowered myocardial acetyl-coenzyme A carboxylase levels, and decreased myocardial transforming growth factor-β1 in CC diet mice. In conclusion, the CC diet induced HFpEF. Reconstituted HDL Milano reversed pathological remodeling and functional cardiac abnormalities.
Original language | English |
---|---|
Article number | 3399 |
Journal | International journal of molecular sciences |
Volume | 19 |
Issue number | 11 |
DOIs | |
Publication status | Published - 30 Oct 2018 |
Externally published | Yes |
Keywords
- Animals
- Apolipoprotein A-I/pharmacology
- Coronary Circulation/drug effects
- Dietary Fats/adverse effects
- Drug Combinations
- Female
- Heart Failure/chemically induced
- Humans
- Lipoproteins, HDL/pharmacology
- Mice
- Microcirculation/drug effects
- Myocardium/metabolism
- Phosphatidylcholines/pharmacology